Structure Therapeutics Inc (GPCR)
31.80
+1.70
(+5.65%)
USD |
NASDAQ |
Nov 22, 10:59
Structure Therapeutics Shareholders Equity (Quarterly): 896.80M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 896.80M |
| June 30, 2024 | 921.03M |
| March 31, 2024 | 429.82M |
| December 31, 2023 | 452.97M |
| September 30, 2023 | 192.96M |
| Date | Value |
|---|---|
| June 30, 2023 | 214.41M |
| March 31, 2023 | 236.35M |
| December 31, 2022 | -115.14M |
| September 30, 2022 | -103.91M |
| December 31, 2021 | -64.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-115.14M
Minimum
Dec 2022
921.03M
Maximum
Jun 2024
306.06M
Average
225.38M
Median
Shareholders Equity (Quarterly) Benchmarks
| Viking Therapeutics Inc | 911.45M |
| Eli Lilly and Co | 14.24B |
| Novo Nordisk AS | 18.05B |
| Pfizer Inc | 92.29B |
| Amgen Inc | 7.527B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 933.22M |
| Total Liabilities (Quarterly) | 36.42M |